The treatment of established intracranial tumors by in situ retroviral IFN-γ transfer

Gene Therapy

Volumn 7, Issue 20, 2000, Pages 1715-1724

  Saleh, M ^a   Jonas, N K ^b   Wiegmans, A ^b   Stylli, S S ^a  

^a UNIVERSITY OF MELBOURNE   (Australia)

^b ROYAL MELBOURNE HOSPITAL   (Australia)

Author keywords

Angiogenesis; Eradication; Glioma; IFN ; Major histocompatibility complex; T cells

Indexed keywords

COMPLEMENTARY DNA; GAMMA INTERFERON; VIRUS VECTOR;

ANGIOGENESIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTINEOPLASTIC ACTIVITY; ARTICLE; B LYMPHOCYTE; BRAIN; CANCER SURVIVAL; CONTROLLED STUDY; DNA PACKAGING; FEMALE; GENE THERAPY; GENE TRANSFER; GENETIC TRANSFECTION; GLIOMA; IMMUNOCOMPETENCE; IMPLANTATION; INTRACRANIAL TUMOR; MORPHOLOGY; MOUSE; NONHUMAN; PRIORITY JOURNAL; RAT; RAT STRAIN; RETROVIRUS; T LYMPHOCYTE; TUMOR VASCULARIZATION;

ANIMALIA; RATTUS NORVEGICUS; UNIDENTIFIED RETROVIRUS;

EID: 0033759005     PISSN: 09697128     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.gt.3301273     Document Type: Article

References (44)

1. Evaluation of BCNU and/or radiation therapy in the treatment of anaplastic gliomas: A cooperative clinical trial
2. Immunotherapy of cancer using local administration of lymphoid cells transformed by IL-2 cDNA and constitutively producing IL-2
3. Gene therapy for metastatic brain tumors by vaccination with granulocyte-macrophage colony-stimulating factor-transduced tumor cells
4. Induction of antitumor immunity by intracerebrally implanted rat C6 glioma cells genetically engineered to secrete cytokines
5. Effective eradication of established murine tumors with IL-12 gene therapy using a polycistronic retroviral vector
6. Effect of in situ retroviral interleukin-4 transfer on established intracranial tumors
7. The paracrine role of tumor-derived mlL-4 on tumor-associated endothelium
8. The role of T cell growth stimulating factors in T cell triggering
9. Role of interleukin 2, interleukin 4, and alpha, beta and gamma interferon in stimulating macrophage antibody-dependent tumoricidal activity
10. IL-2 and IFN-gamma are two necessary lymphokines in the development of cytolytic T cells
11. Preferential effect of interferon on the synthesis of HLA antigens and their mRNAs in human cells
12. Recombinant interferon-γ can induce the expression of HLA-DR and -DC on DR-negative melanoma cells and enhance the expression of HLA-ABC and tumor-associated antigens
13. In vitro antigenic modulation of human neuroblastoma cells induced by interferon-γ, retinoic acid and dibutyryl cyclic AMP
14. Differential effects of interferon gamma and alpha on in vitro model of angiogenesis
15. Interferons in the treatment of malignancies
16. Interferons: New additions and indications for use
17. Retroviral vector-mediated γ-interferon gene transfer into tumour cells generates potent and long-lasting anti-tumour immunity
18. Efficient tumor supression by glioma specific murine cytotoxic T lymphocytes transfected with interferon γ gene
19. Transfection of interferon γ gene in animal tumors a model for local cytokine production and tumor immunity
20. Retrovirus mediated gene transfer of the human gamma IFN gene: A therapy for cancer
21. The immune response elicited by mammary adenocarcinoma cells transduced with interferon-γ and cytosine deaminase genes cures lung metastases by parental cells
22. Experimental gene therapy against subcutaneously implanted glioma with a herpes simplex virus-defective vector expressing interferon-γ
23. Generation of a systemic antitimor response with regional intratumoral injections of interferon γ retroviral therapy
24. A retroviral vector that allows efficient coexpression of two genes and the versatility of alternate selection markers
25. The expression of vascular endothelial platelet endothelial cell adhesion molecule-1 is not regulated by IFN-γ treatment of C6 tumors in vivo
26. Regression of intracerebral rat glioma isografts by therapeutic subcutaneous immunization with interferon-γ, interleukin-7, or B7-1-transfected tumor cells
27. Phase I trial of interferon γ retroviral vector administered intratumorally with multiple courses in patients with metastatic melanoma
28. IFN-γ and TNF-α induce redistribution of PECAM-1 (CD31) on human endothelial cells
29. Inhibition of platelet endothelial cell adhesion molecule-1 synthesis and leukocyte transmigration in endothelial cells by the combined action of TNF-α and IFN-γ
30. Vascular endothelial platelet endothelial cell adhesion molecule-1 (PECAM-1) expression is decreased by TNF-alpha and IFN-gamma
31. Identification of CRG-2. An interferon-inducible mRNA predicted to encode a murine monokine
32. A macrophage mRNA selectively induced by gamma-interferon encodes a member of the platelet factor 4 family of cytokines
33. Human interferon-inducible protein 10 is a potent inhibitor of angiogenesis in vivo
34. The functional role of ELR motif in CXC chemokine-mediated angiogenesis
35. Gene transfer of IFN-gamma into established brain tumors represses growth by antiangiogenesis
36. Therapy of malignant brain tumors by intratumoral implantation of retroviral-producing cells
37. Inhibition of growth of C6 glioma cells in vivo by expression of antisense vascular endothelial growth factor (VEGF) sequence
38. Retroviral gene transfer using safe and efficient packaging cell lines
39. Is angiopoietin-2 necessary for the initiation of tumor angiogenesis
40. Cloning and expression of murine immune interferon cDNA
41. Dicistronic targeting constructs: Reporters and modifiers of mammalian gene expression
42. The expression of antisense vascular endothelial growth factor (VEGF) sequences inhibit intracranial glioma growth in vivo by suppressing tumour angiogenesis
43. Relationship of the extracellular matrix to coronary neovascularisation during development
44. PECAM-1 (CD31) expression in the central nervous system and its role in experimental allergic encephalomyelitis in the rat